Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) Peptide
Quick Overview for Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4) Peptide (ABIN938748)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- GKHTLQPASN SSDAICEDRD PPATQPQETQ GPPARPITVQ PTEAWPRTSQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of TNFRSF4 antibody,
Alternative Names: TNFRSF4 control peptide, TNFRSF4 antibody Blocking Peptide, Anti-TNFRSF4 Blocking Peptide, tumor necrosis factor receptor superfamily, member 4 Blocking Peptide, ACT35 Blocking Peptide, CD134 Blocking Peptide, OX40 Blocking Peptide, TXGP1L Blocking Peptide, TNFRSF4, TNFRSF-4, TNFRSF 4, TNFRSF-4 Blocking Peptide, TNFRSF 4 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Background
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation.
-
Molecular Weight
- 27 kDa
Target
-